Samuel Nurko

Publications

1. Ten-Year Trends in Pharmacologic Management of Gastroesophageal Reflux Disease and Pediatric Feeding Disorders in Young Children. J Pediatr. 2025 Apr 27; 283:114628. View Abstract
2. Use of Digital Rectal Exam Compared With High-Resolution Anorectal Manometry in the Diagnosis of Dyssynergic Defecation in Pediatrics. Neurogastroenterol Motil. 2025 Apr 24; e70061. View Abstract
3. Ethical Considerations for the Use of Deception in Pediatric Research: Reflections on the Use of Deceptive Placebo in Children With Disorders of Gut-Brain Interactions. Gastroenterology. 2025 Apr 04. View Abstract
4. ESPGHAN and NASPGHAN 2024 protocol for paediatric functional constipation treatment guidelines (standard operating procedure). BMJ Paediatr Open. 2025 Feb 04; 9(1). View Abstract
5. Rome Foundation Working Team Report on overlap in disorders of gut-brain interaction. Nat Rev Gastroenterol Hepatol. 2025 Apr; 22(4):228-251. View Abstract
6. Disorders of secondary peristalsis are associated with the development of esophagitis. Neurogastroenterol Motil. 2024 Dec; 36(12):e14943. View Abstract
7. Achieving Enteral Autonomy in Children with Intestinal Failure Following Inpatient Admission: A Case Series. J Pediatr. 2024 Dec; 275:114226. View Abstract
8. Pediatric to adult transition care in neurogastroenterology and motility: A position paper from the American Neurogastroenterology and Motility Society and European Society of Neurogastroenterology and Motility. Neurogastroenterol Motil. 2024 Oct; 36(10):e14869. View Abstract
9. Safety and efficacy of linaclotide in children aged 2-5 years with functional constipation: Phase 2, randomized study. J Pediatr Gastroenterol Nutr. 2024 Sep; 79(3):510-518. View Abstract
10. Hirschsprung's disease. Management. Aliment Pharmacol Ther. 2024 Jul; 60 Suppl 1:S66-S76. View Abstract
11. Impact of Coronavirus disease 2019 pandemic in children with functional abdominal pain disorders: Data from long-term follow-up. J Pediatr Gastroenterol Nutr. 2024 Jul; 79(1):26-34. View Abstract
12. Randomized controlled trial of linaclotide in children aged 6-17 years with functional constipation. J Pediatr Gastroenterol Nutr. 2024 May; 78(5):1059-1068. View Abstract
13. A multicenter registry study on percutaneous electrical nerve field stimulation for pediatric disorders of gut-brain interaction. J Pediatr Gastroenterol Nutr. 2024 Apr; 78(4):817-826. View Abstract
14. Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Gastroenterol Hepatol. 2024 Mar; 9(3):238-250. View Abstract
15. Safety and efficacy of linaclotide in children aged 7-17 years with irritable bowel syndrome with constipation. J Pediatr Gastroenterol Nutr. 2024 Mar; 78(3):539-547. View Abstract
16. The utility of balloon-based and standard impedance technology to diagnose esophageal mucosal diseases in children. Neurogastroenterol Motil. 2024 Mar; 36(3):e14726. View Abstract
17. The Effect of Dexmedetomidine Sedation on Lower Gastrointestinal Motility in Children-Is It Suitable for Anorectal Manometry? J Clin Med. 2023 Dec 04; 12(23). View Abstract
18. The Clinical Utility of Antroduodenal Manometry in the Evaluation of Children with Upper Gastrointestinal Symptoms. J Pediatr Gastroenterol Nutr. 2023 12 01; 77(6):734-740. View Abstract
19. Simultaneous Colonic Pressure Waves in Children and Young Adults with Gastrointestinal Motility Disorders: Artefact or Colonic Physiology? J Clin Med. 2023 Sep 06; 12(18). View Abstract
20. First study to assess the reliability of commonly used pain scales in children with disorders of gut-brain interaction. Neurogastroenterol Motil. 2023 09; 35(9):e14636. View Abstract
21. Award Recipients for Pediatric Gastroenterology: A Descriptive Analysis of Gender Distribution. J Pediatr Gastroenterol Nutr. 2023 12 01; 77(6):e99-e103. View Abstract
22. Clinical Utility of Ileal Motility in Children With Defecation Disorders and Children With Chronic Intestinal Pseudo-Obstruction. J Pediatr Gastroenterol Nutr. 2023 09 01; 77(3):327-331. View Abstract
23. Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial. J Pediatr Gastroenterol Nutr. 2023 08 01; 77(2):e49-e50. View Abstract
24. Clinical utility of colonic low-amplitude propagating contractions in children with functional constipation. Neurogastroenterol Motil. 2023 05; 35(5):e14543. View Abstract
25. Differences in rectoanal inhibitory reflex duration between patients with refractory functional constipationand myelomeningocele. Arch Argent Pediatr. 2023 04 01; 121(2):e202202598. View Abstract
26. Airway Impedance: A Novel Diagnostic Tool to Predict Extraesophageal Airway Inflammation. J Pediatr. 2023 05; 256:5-10.e2. View Abstract
27. Author response to letter to the editor. Neurogastroenterol Motil. 2022 Dec; 34(12):e14478. View Abstract
28. A Quality Improvement Initiative to Reduce Abdominal X-ray use in Pediatric Patients Presenting with Constipation. J Pediatr. 2022 12; 251:127-133. View Abstract
29. Diverting Ileostomy in Children With Functional Constipation: A Study Evaluating the Utility of Colon Manometry. J Pediatr Gastroenterol Nutr. 2022 11 01; 75(5):578-583. View Abstract
30. A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting. Neurogastroenterol Motil. 2022 Nov; 34(11):e14428. View Abstract
31. Pediatric Aspects of Nutrition Interventions for Disorders of Gut-Brain Interaction. Am J Gastroenterol. 2022 06 01; 117(6):995-1009. View Abstract
32. Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial. JAMA Pediatr. 2022 04 01; 176(4):349-356. View Abstract
33. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clin Gastroenterol Hepatol. 2022 11; 20(11):2474-2484.e3. View Abstract
34. The Utility of Functional Luminal Imaging Probes Measurements to Diagnose Dysmotility and Their Relationship to Impaired Bolus Clearance. J Pediatr Gastroenterol Nutr. 2022 04 01; 74(4):523-528. View Abstract
35. Autoimmune gastrointestinal dysmotility following SARS-CoV-2 infection successfully treated with intravenous immunoglobulin. Neurogastroenterol Motil. 2022 07; 34(7):e14314. View Abstract
36. Can Propofol Be Used to Assess the Presence of the Rectoanal Inhibitory Reflex During Anorectal Manometry Studies? J Pediatr Gastroenterol Nutr. 2022 01 01; 74(1):33-37. View Abstract
37. Prucalopride for Treatment of Upper Gastrointestinal Symptoms in Children. Paediatr Drugs. 2022 Jan; 24(1):73-81. View Abstract
38. Impact of Coronavirus Disease 2019 on the Pediatric Population with Aerodigestive Disease. J Pediatr. 2022 04; 243:14-20.e1. View Abstract
39. Overall Impact of Coronavirus Disease 2019 Outbreak in Children With Functional Abdominal Pain Disorders: Results From the First Pandemic Phase. J Pediatr Gastroenterol Nutr. 2021 12 01; 73(6):689-694. View Abstract
40. Bile Acid Diarrhea in Adults and Adolescents. Neurogastroenterol Motil. 2022 04; 34(4):e14287. View Abstract
41. Melanosis Coli Is Not Associated with Colonic Dysmotility Nor Severity of Pediatric Functional Constipation. Dig Dis Sci. 2022 08; 67(8):3922-3928. View Abstract
42. Pharmacogenomics fail to explain proton pump inhibitor refractory esophagitis in pediatric esophageal atresia. Neurogastroenterol Motil. 2022 01; 34(1):e14217. View Abstract
43. A Collaborative Effort to Advance Drug Development in Pediatric Constipation and Irritable Bowel Syndrome. J Pediatr Gastroenterol Nutr. 2021 08 01; 73(2):145-149. View Abstract
44. PedsQL™ Gastroparesis Symptoms Module Domain and Item Development: Qualitative Methods. J Pediatr Gastroenterol Nutr. 2021 08 01; 73(2):192-196. View Abstract
45. A Review of the Evidence and Recommendations on Communication Skills and the Patient-Provider Relationship: A Rome Foundation Working Team Report. Gastroenterology. 2021 11; 161(5):1670-1688.e7. View Abstract
46. Duodenal and proximal jejunal motility inhibition associated with bisacodyl-induced colonic high-amplitude propagating contractions. Am J Physiol Gastrointest Liver Physiol. 2021 09 01; 321(3):G325-G334. View Abstract
47. Response to Febo-Rodriguez et al. Am J Gastroenterol. 2021 07 01; 116(7):1553. View Abstract
48. Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls. J Pediatr Gastroenterol Nutr. 2021 06 01; 72(6):859-865. View Abstract
49. Lubiprostone for Pediatric Functional Constipation: Randomized, Controlled, Double-Blind Study With Long-term Extension. Clin Gastroenterol Hepatol. 2022 03; 20(3):602-610.e5. View Abstract
50. Healthcare spending and utilization for pediatric Irritable Bowel Syndrome in a commercially insured population. Neurogastroenterol Motil. 2021 11; 33(11):e14147. View Abstract
51. Evaluation of Fecal Incontinence in Pediatric Functional Constipation: Clinical Utility of Anorectal and Colon Manometry. J Pediatr Gastroenterol Nutr. 2021 03 01; 72(3):361-365. View Abstract
52. Development of Entrustable Professional Activities and Standards in Training in Pediatric Neurogastroenterology and Motility: North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and American Neurogastroenterology and Motility Society Position Paper. J Pediatr Gastroenterol Nutr. 2021 01 01; 72(1):168-180. View Abstract
53. The Golden Half Hour in Chronic Pediatric Pain-Feedback as the First Intervention. JAMA Pediatr. 2021 01 01; 175(1):7-8. View Abstract
54. Diagnostic and clinical utility of the wireless motility capsule in children: A study in patients with functional gastrointestinal disorders. Neurogastroenterol Motil. 2021 04; 33(4):e14032. View Abstract
55. Paediatric functional abdominal pain disorders. Nat Rev Dis Primers. 2020 11 05; 6(1):89. View Abstract
56. Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. Am J Gastroenterol. 2020 11; 115(11):1830-1839. View Abstract
57. Comparison of longitudinal and radial characteristics of intra-anal pressures using 3D high-definition anorectal manometry between children with anoretal malformations and functional constipation. Neurogastroenterol Motil. 2021 02; 33(2):e13971. View Abstract
58. Long-term Use of Bisacodyl in Pediatric Functional Constipation Refractory to Conventional Therapy. J Pediatr Gastroenterol Nutr. 2020 09; 71(3):288-291. View Abstract
59. Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. Am J Gastroenterol. 2020 Aug 19. View Abstract
60. Proceedings of the 2018 Advances In Motility and In NeuroGastroenterology: AIMING for the Future Single Topic Symposium. J Pediatr Gastroenterol Nutr. 2020 08; 71(2):e59-e67. View Abstract
61. Perceptions of Pain Treatment in Pediatric Patients With Functional Gastrointestinal Disorders. Clin J Pain. 2020 07; 36(7):550-557. View Abstract
62. Botulinum Toxin as a Treatment for Feeding Difficulties in Young Children. J Pediatr. 2020 11; 226:228-235. View Abstract
63. Interleukin-10 and Zonulin Are Associated With Postoperative Delayed Gastric Emptying in Critically Ill Surgical Pediatric Patients: A Prospective Pilot Study. JPEN J Parenter Enteral Nutr. 2020 11; 44(8):1407-1416. View Abstract
64. Functional Luminal Imaging Probe Assessment in Postfundoplication Patients Changes Management Beyond Manometry. J Pediatr Gastroenterol Nutr. 2020 06; 70(6):e119-e123. View Abstract
65. Characterization of the colonic response to bisacodyl in children with treatment-refractory constipation. Neurogastroenterol Motil. 2020 08; 32(8):e13851. View Abstract
66. Omeprazole inhibits IgE-mediated mast cell activation and allergic inflammation induced by ingested allergen in mice. J Allergy Clin Immunol. 2020 10; 146(4):884-893.e5. View Abstract
67. Functional Luminal Imaging Probe Assessment in Post-Fundoplication Patients Changes Management Beyond Manometry. J Pediatr Gastroenterol Nutr. 2020 Feb 11. View Abstract
68. Utility of Colon Manometry in Guiding Therapy and Predicting Need for Surgery in Children With Defecation Disorders. J Pediatr Gastroenterol Nutr. 2020 02; 70(2):232-237. View Abstract
69. It Is Ok to Be Negative! J Pediatr Gastroenterol Nutr. 2019 10; 69(4):393-394. View Abstract
70. Unintentional Symptom Intensification by Doctors. Pediatrics. 2019 11; 144(5). View Abstract
71. Utility of Colon Manometry in Guiding Therapy and Predicting Need for Surgery in Children With Defecation Disorders. J Pediatr Gastroenterol Nutr. 2019 Sep 17. View Abstract
72. Gastrointestinal Dysmotility and the Implications for Respiratory Disease. Curr Treat Options Pediatr. 2019 Jun; 5(2):197-214. View Abstract
73. Mechanical Skin Injury Promotes Food Anaphylaxis by Driving Intestinal Mast Cell Expansion. Immunity. 2019 05 21; 50(5):1262-1275.e4. View Abstract
74. Chronic Acalculous Cholecystitis in Children With Biliary Symptoms: Usefulness of Hepatocholescintigraphy. J Pediatr Gastroenterol Nutr. 2019 01; 68(1):68-73. View Abstract
75. Same day versus next day antroduodenal manometry results in children with upper gastrointestinal symptoms: A prospective study. Neurogastroenterol Motil. 2019 03; 31(3):e13521. View Abstract
76. A Distinct Esophageal mRNA Pattern Identifies Eosinophilic Esophagitis Patients With Food Impactions. Front Immunol. 2018; 9:2059. View Abstract
77. Primary placement of a skin-level Cecostomy Tube for Antegrade Colonic Enema Administration Using a Modification of the Laparoscopic-Assisted Percutaneous Endoscopic Cecostomy (LAPEC). J Pediatr Surg. 2019 Mar; 54(3):486-490. View Abstract
78. Focus on the use of antidepressants to treat pediatric functional abdominal pain: current perspectives. Clin Exp Gastroenterol. 2018; 11:365-372. View Abstract
79. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018 10; 155(4):1022-1033.e10. View Abstract
80. Microstructural White Matter Abnormalities in the Dorsal Cingulum of Adolescents with IBS. eNeuro. 2018 Jul-Aug; 5(4). View Abstract
81. Multidisciplinary Treatment Reduces Pain and Increases Function in Children With Functional Gastrointestinal Disorders. Clin Gastroenterol Hepatol. 2019 04; 17(5):994-996. View Abstract
82. Thoracoscopic esophagomyotomy for achalasia in the pediatric population: A retrospective cohort study. J Pediatr Surg. 2019 Mar; 54(3):572-576. View Abstract
83. Educational needs in the diagnosis and management of pediatric functional constipation: a US survey of specialist and primary care clinicians. Postgrad Med. 2018 May; 130(4):428-435. View Abstract
84. Prevalence of Pediatric Functional Gastrointestinal Disorders Utilizing the Rome IV Criteria. J Pediatr. 2018 04; 195:134-139. View Abstract
85. Novel Pressure-Impedance Parameters for Evaluating Esophageal Function in Pediatric Achalasia. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):37-42. View Abstract
86. An algorithm for the classification of mRNA patterns in eosinophilic esophagitis: Integration of machine learning. J Allergy Clin Immunol. 2018 04; 141(4):1354-1364.e9. View Abstract
87. Are We Using Abdominal Radiographs Appropriately in the Management of Pediatric Constipation? J Pediatr. 2017 12; 191:179-183. View Abstract
88. An ANMS-NASPGHAN consensus document on esophageal and antroduodenal manometry in children. Neurogastroenterol Motil. 2018 03; 30(3). View Abstract
89. Perceived medication adherence barriers mediating effects between gastrointestinal symptoms and health-related quality of life in pediatric inflammatory bowel disease. Qual Life Res. 2018 01; 27(1):195-204. View Abstract
90. Rectal Suction Biopsy in Patients With Previous Anorectal Surgery for Hirschsprung Disease. J Pediatr Gastroenterol Nutr. 2017 08; 65(2):173-178. View Abstract
91. Spontaneous food allergy in Was-/- mice occurs independent of FceRI-mediated mast cell activation. Allergy. 2017 Dec; 72(12):1916-1924. View Abstract
92. The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children. J Pediatr. 2017 10; 189:86-91. View Abstract
93. Motility Disorders in Children. Pediatr Clin North Am. 2017 06; 64(3):593-612. View Abstract
94. Patient Health Communication Mediating Effects Between Gastrointestinal Symptoms and Gastrointestinal Worry in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 05; 23(5):704-711. View Abstract
95. Empirically Derived Patterns of Pain, Stooling, and Incontinence and Their Relations to Health-Related Quality of Life Among Youth With Chronic Constipation. J Pediatr Psychol. 2017 Apr 01; 42(3):325-334. View Abstract
96. Prospective evaluation of same day versus next day colon manometry results in children with medical refractory constipation. Neurogastroenterol Motil. 2017 Jul; 29(7). View Abstract
97. The pediatric Rome IV criteria: what's new? Expert Rev Gastroenterol Hepatol. 2017 Mar; 11(3):193-201. View Abstract
98. Gastric Emptying in Critically Ill Children. JPEN J Parenter Enteral Nutr. 2017 09; 41(7):1100-1109. View Abstract
99. Pediatric rumination subtypes: A study using high-resolution esophageal manometry with impedance. Neurogastroenterol Motil. 2017 05; 29(5). View Abstract
100. Gastrointestinal Symptoms Predictors of Health-Related Quality of Life in Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2016 12; 63(6):e186-e192. View Abstract
101. Gastrointestinal symptoms predictors of health-related quality of life in pediatric patients with functional gastrointestinal disorders. Qual Life Res. 2017 04; 26(4):1015-1025. View Abstract
102. Utility of Octreotide in Advancing Enteral Feeds in Children with Chronic Intestinal Pseudo-Obstruction. Paediatr Drugs. 2016 Oct; 18(5):387-92. View Abstract
103. Eosinophilic esophagitis: published evidences for disease subtypes, indications for patient subpopulations, and how to translate patient observations to murine experimental models. World Allergy Organ J. 2016; 9:23. View Abstract
104. Abdominal Pain, the Adolescent and Altered Brain Structure and Function. PLoS One. 2016; 11(5):e0156545. View Abstract
105. Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33-basophil axis in mice. J Allergy Clin Immunol. 2016 11; 138(5):1367-1380.e5. View Abstract
106. Simultaneous urodynamic and anorectal manometry studies in children: insights into the relationship between the lower gastrointestinal and lower urinary tracts. Neurogastroenterol Motil. 2016 06; 28(6):924-33. View Abstract
107. Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterology. 2016 Feb 15. View Abstract
108. Acid Rather Than Nonacid Reflux Burden Is a Predictor of Tooth Erosion. J Pediatr Gastroenterol Nutr. 2016 Feb; 62(2):309-13. View Abstract
109. Gastric Dysmotility in Critically Ill Children: Pathophysiology, Diagnosis, and Management. Pediatr Crit Care Med. 2015 Nov; 16(9):828-36. View Abstract
110. Pediatric Functional Constipation Gastrointestinal Symptom Profile Compared With Healthy Controls. J Pediatr Gastroenterol Nutr. 2015 Oct; 61(4):424-30. View Abstract
111. Symptom Profiles in Patients With Irritable Bowel Syndrome or Functional Abdominal Pain Compared With Healthy Controls. J Pediatr Gastroenterol Nutr. 2015 Sep; 61(3):323-9. View Abstract
112. Effect of anesthesia on gastroesophageal reflux in children: a study using BRAVO wireless pH study measurements. Neurogastroenterol Motil. 2015 Nov; 27(11):1553-8. View Abstract
113. Accuracy of digital mRNA profiling of oesophageal biopsies as a novel diagnostic approach to eosinophilic oesophagitis. Clin Exp Allergy. 2015 Aug; 45(8):1317-1327. View Abstract
114. High-resolution manometry combined with impedance measurements discriminates the cause of dysphagia in children. Eur J Pediatr. 2015 Dec; 174(12):1629-37. View Abstract
115. Validation of a bowel dysfunction instrument for adolescents with spina bifida. J Pediatr Urol. 2015 Aug; 11(4):199.e1-7. View Abstract
116. A multicenter study on childhood constipation and fecal incontinence: effects on quality of life. J Pediatr. 2015 Jun; 166(6):1482-7.e1. View Abstract
117. PedsQL gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with inflammatory bowel disease in comparison with healthy controls. Inflamm Bowel Dis. 2015 May; 21(5):1115-24. View Abstract
118. Shared care: a quality improvement initiative to optimize primary care management of constipation. Pediatrics. 2015 May; 135(5):e1300-7. View Abstract
119. Measuring Health-Related Quality of Life With the Parental Opinions of Pediatric Constipation Questionnaire. J Pediatr Psychol. 2015 Sep; 40(8):814-24. View Abstract
120. Emergency department burden of constipation in the United States from 2006 to 2011. Am J Gastroenterol. 2015 Apr; 110(4):572-9. View Abstract
121. Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009. Neurogastroenterol Motil. 2015 May; 27(5):684-92. View Abstract
122. Interpretability of the PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in Pediatric Patients With Functional and Organic Gastrointestinal Diseases. J Pediatr Psychol. 2015 Jul; 40(6):591-601. View Abstract
123. Treating constipation with prucalopride: one size does not fit all. Gastroenterology. 2014 Dec; 147(6):1214-6. View Abstract
124. Health-related quality of life in pediatric patients with functional and organic gastrointestinal diseases. J Pediatr. 2015 Jan; 166(1):85-90. View Abstract
125. PedsQL gastrointestinal symptoms module: feasibility, reliability, and validity. J Pediatr Gastroenterol Nutr. 2014 Sep; 59(3):347-55. View Abstract
126. PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in pediatric patients with functional and organic gastrointestinal diseases in comparison to healthy controls. Qual Life Res. 2015 Feb; 24(2):363-78. View Abstract
127. Evaluation and treatment of constipation in children and adolescents. Am Fam Physician. 2014 Jul 15; 90(2):82-90. View Abstract
128. Persistent pain in chronically ill children without detectable disease activity. Pain Manag. 2014 May; 4(3):211-9. View Abstract
129. Functional dyspepsia in children. Pediatr Ann. 2014 Apr; 43(4):e101-5. View Abstract
130. Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy. Am J Gastroenterol. 2014 May; 109(5):646-57. View Abstract
131. Intraesophageal pressure recording improves the detection of cough during multichannel intraluminal impedance testing in children. J Pediatr Gastroenterol Nutr. 2014 Jan; 58(1):22-6. View Abstract
132. Assessment of abdominal pain through global outcomes and recent FDA recommendations in children: are we ready for change? J Pediatr Gastroenterol Nutr. 2014 Jan; 58(1):46-50. View Abstract
133. The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. Pediatr Pulmonol. 2014 Nov; 49(11):1090-6. View Abstract
134. Longitudinal and radial characteristics of intra-anal pressures in children using 3D high-definition anorectal manometry: new observations. Am J Gastroenterol. 2013 Dec; 108(12):1918-28. View Abstract
135. Review of organic causes of fecal incontinence in children: evaluation and treatment. Expert Rev Gastroenterol Hepatol. 2013 Sep; 7(7):657-67. View Abstract
136. Elevated levels of leukotriene C4 synthase mRNA distinguish a subpopulation of eosinophilic oesophagitis patients. Clin Exp Allergy. 2013 Aug; 43(8):902-13. View Abstract
137. The overlap of functional abdominal pain in pediatric Crohn's disease. Inflamm Bowel Dis. 2013 Mar-Apr; 19(4):826-31. View Abstract
138. Relationship between postprandial metabolomics and colon motility in children with constipation. Neurogastroenterol Motil. 2013 May; 25(5):420-6, e299. View Abstract
139. Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children. J Pediatr. 2013 Jul; 163(1):261-7. View Abstract
140. Factors associated with successful decrease and discontinuation of antegrade continence enemas (ACE) in children with defecation disorders: a study evaluating the effect of ACE on colon motility. Neurogastroenterol Motil. 2013 Feb; 25(2):140-e81. View Abstract
141. Accuracy of pain recall in children. J Pediatr Gastroenterol Nutr. 2012 Sep; 55(3):288-91. View Abstract
142. Fc-epsilon-RI, the high affinity IgE-receptor, is robustly expressed in the upper gastrointestinal tract and modulated by mucosal inflammation. PLoS One. 2012; 7(7):e42066. View Abstract
143. Internal anal sphincter relaxation associated with bisacodyl-induced colonic high amplitude propagating contractions in children with constipation: a colo-anal reflex? Neurogastroenterol Motil. 2012 Nov; 24(11):1023-e545. View Abstract
144. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study. Gastrointest Endosc. 2012 Feb; 75(2):302-9. View Abstract
145. Heterogeneity of lower esophageal sphincter function in children with achalasia. J Pediatr Gastroenterol Nutr. 2012 Jan; 54(1):34-40. View Abstract
146. The presence of pepsin in the lung and its relationship to pathologic gastro-esophageal reflux. Neurogastroenterol Motil. 2012 Feb; 24(2):129-33, e84-5. View Abstract
147. Eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2011 Dec; 53 Suppl 2:S13-5. View Abstract
148. Extra-esophageal symptoms: how do we treat them? J Pediatr Gastroenterol Nutr. 2011 Dec; 53 Suppl 2:S22-3. View Abstract
149. Anorectal manometry may identify children with spinal cord lesions. J Pediatr Gastroenterol Nutr. 2011 Nov; 53(5):507-11. View Abstract
150. 50 years ago in the journal of pediatrics achalasia in children as a cause of recurrent pulmonary disease. J Pediatr. 2011 Oct; 159(4):632. View Abstract
151. Esophageal disease in pediatrics. Ann N Y Acad Sci. 2011 Sep; 1232:401-4. View Abstract
152. Development and validation of a standardized ELISA for the detection of soluble Fc-epsilon-RI in human serum. J Immunol Methods. 2011 Oct 28; 373(1-2):192-9. View Abstract
153. Higher rate of bronchoalveolar lavage culture positivity in children with nonacid reflux and respiratory disorders. J Pediatr. 2011 Sep; 159(3):504-6. View Abstract
154. Defecation disorders in children after surgery for Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2011 Jul; 53(1):75-9. View Abstract
155. [Esophageal impedance monitoring for gastroesophageal reflux]. Acta Gastroenterol Latinoam. 2011 Jun; 41(2):146-61. View Abstract
156. Diagnosis of supra-esophageal gastric reflux: correlation of oropharyngeal pH with esophageal impedance monitoring for gastro-esophageal reflux. Neurogastroenterol Motil. 2011 Aug; 23(8):717-e326. View Abstract
157. Long-term follow-up of patients after antegrade continence enema procedure. J Pediatr Gastroenterol Nutr. 2011 May; 52(5):574-80. View Abstract
158. Cisapride improves enteral tolerance in pediatric short-bowel syndrome with dysmotility. J Pediatr Gastroenterol Nutr. 2011 May; 52(5):590-4. View Abstract
159. Functional abdominal pain and irritable bowel syndrome in children and adolescents. Therapy. 2011 May 01; 8(3):315-331. View Abstract
160. A soluble form of the high affinity IgE receptor, Fc-epsilon-RI, circulates in human serum. PLoS One. 2011 Apr 22; 6(4):e19098. View Abstract
161. Beliefs and attitudes of general pediatricians and pediatric gastroenterologists regarding functional gastrointestinal disorders: a survey study. Clin Pediatr (Phila). 2011 Oct; 50(10):891-6. View Abstract
162. Effect of different pH criteria on dual-sensor pH monitoring in the evaluation of supraesophageal gastric reflux in children. J Pediatr Gastroenterol Nutr. 2011 Apr; 52(4):399-403. View Abstract
163. Does reflux monitoring with multichannel intraluminal impedance change clinical decision making? J Pediatr Gastroenterol Nutr. 2011 Apr; 52(4):404-7. View Abstract
164. Esophageal impedance monitoring for gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2011 Feb; 52(2):129-39. View Abstract
165. Coexistence of constipation and incontinence in children and adults. Best Pract Res Clin Gastroenterol. 2011 Feb; 25(1):29-41. View Abstract
166. Comparative analysis of FceRI expression patterns in patients with eosinophilic and reflux esophagitis. J Pediatr Gastroenterol Nutr. 2010 Nov; 51(5):584-92. View Abstract
167. Relationships between levels of serum IgE, cell-bound IgE, and IgE-receptors on peripheral blood cells in a pediatric population. PLoS One. 2010 Aug 16; 5(8):e12204. View Abstract
168. Lack of utility of abdominal x-rays in the evaluation of children with constipation: comparison of different scoring methods. J Pediatr Gastroenterol Nutr. 2010 Aug; 51(2):155-9. View Abstract
169. Management of functional abdominal pain and irritable bowel syndrome in children and adolescents. Expert Rev Gastroenterol Hepatol. 2010 Jun; 4(3):293-304. View Abstract
170. Reflux events detected by pH-MII do not determine fundoplication outcome. J Pediatr Gastroenterol Nutr. 2010 Mar; 50(3):251-5. View Abstract
171. Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry. Am J Gastroenterol. 2009 Dec; 104(12):3050-7. View Abstract
172. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009 Oct; 137(4):1261-9. View Abstract
173. Congenital myasthenic syndrome with episodic apnea. Pediatr Neurol. 2009 Jul; 41(1):42-5. View Abstract
174. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter. Am J Gastroenterol. 2009 Apr; 104(4):976-83. View Abstract
175. The tip of the iceberg: the prevalence of functional gastrointestinal diseases in children. J Pediatr. 2009 Mar; 154(3):313-5. View Abstract
176. Preservation of intestinal motility after the serial transverse enteroplasty procedure in a large animal model of short bowel syndrome. J Pediatr Surg. 2009 Jan; 44(1):229-35; discussion 235. View Abstract
177. Functional abdominal pain: time to get together and move forward. J Pediatr Gastroenterol Nutr. 2008 Nov; 47(5):679-80. View Abstract
178. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency. J Allergy Clin Immunol. 2008 Dec; 122(6):1113-1118.e1. View Abstract
179. Approach to the child who has persistent dysphagia after surgical treatment for esophageal achalasia. J Pediatr Gastroenterol Nutr. 2008 Jul; 47(1):92-7. View Abstract
180. Opioid side effects--mechanism-based therapy. N Engl J Med. 2008 May 29; 358(22):2400-2. View Abstract
181. Role of acid and nonacid reflux in children with eosinophilic esophagitis compared with patients with gastroesophageal reflux and control patients. J Pediatr Gastroenterol Nutr. 2008 May; 46(5):520-3. View Abstract
182. Lipid-laden macrophage index is not an indicator of gastroesophageal reflux-related respiratory disease in children. Pediatrics. 2008 Apr; 121(4):e879-84. View Abstract
183. PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial. J Pediatr. 2008 Aug; 153(2):254-61, 261.e1. View Abstract
184. Pediatric gastrointestinal motility disorders: challenges and a clinical update. Gastroenterol Hepatol (N Y). 2008 Feb; 4(2):140-8. View Abstract
185. Esophageal dysmotility in patients who have eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008 Jan; 18(1):73-89; ix. View Abstract
186. The sensitivity of multichannel intraluminal impedance and the pH probe in the evaluation of gastroesophageal reflux in children. Clin Gastroenterol Hepatol. 2006 Feb; 4(2):167-72. View Abstract
187. What's the value of diagnostic tools in defecation disorders? J Pediatr Gastroenterol Nutr. 2005 Sep; 41 Suppl 1:S53-5. View Abstract
188. Use of multi-channel intraluminal impedance (MII) in the evaluation of children with respiratory symptoms: a new phenomenon? J Pediatr Gastroenterol Nutr. 2005 Aug; 41(2):166-8. View Abstract
189. The Paris Consensus on Childhood Constipation Terminology (PACCT) Group. J Pediatr Gastroenterol Nutr. 2005 Mar; 40(3):273-5. View Abstract
190. Esophageal motor activity in children with gastro-esophageal reflux disease and esophagitis. J Pediatr Gastroenterol Nutr. 2005 Jan; 40(1):70-5. View Abstract
191. The importance of multichannel intraluminal impedance in the evaluation of children with persistent respiratory symptoms. Am J Gastroenterol. 2004 Dec; 99(12):2452-8. View Abstract
192. Management of Fecal Incontinence in Children Without Functional Fecal Retention. Curr Treat Options Gastroenterol. 2004 Oct; 7(5):381-390. View Abstract
193. Incidence of spinal cord lesions in patients with intractable constipation. J Pediatr. 2004 Sep; 145(3):409-11. View Abstract
194. Increased prevalence of constipation and fecal soiling in a population of obese children. J Pediatr. 2004 Aug; 145(2):253-4. View Abstract
195. The importance of gut motility in the metabolic control of propionic acidemia. J Pediatr. 2004 Apr; 144(4):532-5. View Abstract
196. Association of Schatzki ring with eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2004 Apr; 38(4):436-41. View Abstract
197. Prolonged monitoring of esophageal motor function in healthy children. J Pediatr Gastroenterol Nutr. 2004 Feb; 38(2):192-7. View Abstract
198. Acute myeloid leukemia presenting as non-neutropenic colitis in an infant. J Pediatr Gastroenterol Nutr. 2003 Nov; 37(5):631-3. View Abstract
199. Impeding gastroesophageal refluxate: a new application of an old medication. Gastroenterology. 2003 Sep; 125(3):984-5; discussion 985-6. View Abstract
200. Internal anal sphincter achalasia in children: clinical characteristics and treatment with Clostridium botulinum toxin. J Pediatr Gastroenterol Nutr. 2003 Sep; 37(3):315-9. View Abstract
201. Stimulation with fatty meal (Lipomul) to assess gallbladder emptying in children with chronic acalculous cholecystitis. J Pediatr Gastroenterol Nutr. 2003 Aug; 37(2):178-82. View Abstract
202. Rectal manometry in patients with isolated sacral agenesis. J Pediatr Gastroenterol Nutr. 2003 Jul; 37(1):47-52. View Abstract
203. Trends in referral to a single encopresis clinic over 20 years. Pediatrics. 2003 May; 111(5 Pt 1):e604-7. View Abstract
204. Abnormalities in gastrointestinal motility are associated with diseases of oxidative phosphorylation in children. Am J Gastroenterol. 2003 Apr; 98(4):871-7. View Abstract
205. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg. 2003 Mar; 38(3):425-9. View Abstract
206. Isolated neonatal swallowing dysfunction: a case series and review of the literature. Dig Dis Sci. 2003 Jan; 48(1):30-5. View Abstract
207. High-resolution EUS in children with eosinophilic "allergic" esophagitis. Gastrointest Endosc. 2003 Jan; 57(1):30-6. View Abstract
208. Diagnosis and management of MNGIE syndrome in children: case report and review of the literature. J Pediatr Gastroenterol Nutr. 2002 Sep; 35(3):377-83. View Abstract
209. Eosinophilic esophagitis: it's not just kid's stuff. Gastrointest Endosc. 2002 Aug; 56(2):260-70. View Abstract
210. Manometry studies in children: minimum standards for procedures. Neurogastroenterol Motil. 2002 Aug; 14(4):411-20. View Abstract
211. Gastrointestinal complications after pediatric cardiac transplantation. J Heart Lung Transplant. 2002 Jul; 21(7):751-9. View Abstract
212. The infant with chronic vomiting: the value of the upper GI series. Pediatr Radiol. 2002 Aug; 32(8):549-50; discussion 551. View Abstract
213. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest. 2002 Jun; 109(11):1501-9. View Abstract
214. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology. 2002 May; 122(5):1216-25. View Abstract
215. Early constipation and toilet training in children with encopresis. J Pediatr Gastroenterol Nutr. 2002 Apr; 34(4):385-8. View Abstract
216. Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med. 2001 Apr; 29(4):870-7. View Abstract
217. Nonfixation of an atretic colon predicts Hirschsprung's disease. J Pediatr Surg. 2001 Jan; 36(1):202-4. View Abstract
218. The spectrum of pediatric gastroesophageal reflux. JAMA. 2000 Dec 27; 284(24):3125-6. View Abstract
219. The barium enema in constipation: comparison with rectal manometry and biopsy to exclude Hirschsprung's disease after the neonatal period. Pediatr Radiol. 2000 Oct; 30(10):681-4. View Abstract
220. Advances in the management of pediatric constipation. Curr Gastroenterol Rep. 2000 Jun; 2(3):234-40. View Abstract
221. The efficacy of cisapride: what is needed for digestion? J Pediatr Gastroenterol Nutr. 2000 Mar; 30(3):230-1. View Abstract
222. Cisapride for the treatment of constipation in children: A double-blind study. J Pediatr. 2000 Jan; 136(1):35-40. View Abstract
223. Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 1999 Nov; 29(5):612-26. View Abstract
224. Barrett's esophagus in a teenager with a ringed esophagus. Pediatr Radiol. 1999 Aug; 29(8):641. View Abstract
225. Cisapride for the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 1999 Jul; 29(1):7. View Abstract
226. Allergic colitis: a mimic of Hirschsprung disease. Pediatr Radiol. 1999 Jan; 29(1):37-41. View Abstract
227. Intraduodenal hematoma complicating intestinal biopsy: case reports and review of the literature. Am J Gastroenterol. 1998 Dec; 93(12):2547-50. View Abstract
228. Schatzki ring in children and young adults: clinical and radiologic findings. Pediatr Radiol. 1998 Nov; 28(11):884-6. View Abstract
229. Benefit of uncooked cornstarch in the management of children with dumping syndrome fed exclusively by gastrostomy. Am J Gastroenterol. 1998 May; 93(5):814-8. View Abstract
230. Use of octreotide for the treatment of severe gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr. 1998 Mar; 26(3):356-9. View Abstract
231. "Feeding the gut": the scientific basis for continued enteral nutrition during acute diarrhea. J Pediatr. 1997 Dec; 131(6):801-8. View Abstract
232. Successful use of a chicken-based diet for the treatment of severely malnourished children with persistent diarrhea: a prospective, randomized study. J Pediatr. 1997 Sep; 131(3):405-12. View Abstract
233. Botulinum toxin for achalasia: are we witnessing the birth of a new era? J Pediatr Gastroenterol Nutr. 1997 Apr; 24(4):447-9. View Abstract
234. Treatment of intractable constipation in children: experience with cisapride. J Pediatr Gastroenterol Nutr. 1996 Jan; 22(1):38-44. View Abstract
235. Anorectal function in children after ileoanal pull-through. J Pediatr Surg. 1994 Feb; 29(2):329-32; discussion 332-3. View Abstract
236. Role of neuropeptide Y in opossum internal anal sphincter. Am J Physiol. 1990 Jan; 258(1 Pt 1):G59-64. View Abstract
237. Peptide histidine isoleucine and vasoactive intestinal polypeptide cause relaxation of opossum internal anal sphincter via two distinct receptors. Gastroenterology. 1989 Feb; 96(2 Pt 1):403-13. View Abstract
238. Role of vasoactive intestinal polypeptide in the internal anal sphincter relaxation of the opossum. J Clin Invest. 1988 Apr; 81(4):1146-53. View Abstract
239. Pectus carinatum and pectus excavatum: are they the same disease? Am Surg. 1981 May; 47(5):215-8. View Abstract
240. [Neurogenic bladder in children. Analysis of the most adequate method for the treatment in our area (review of 6 years of experience at the Hospital del Niño DIF)]. Actas Urol Esp. 1979 Nov-Dec; 3(6):337-44. View Abstract
Show All Publications Show Fewer Publications